Comparison of posaconazole and voriconazole in vitro killing against Candida krusei

Diagn Microbiol Infect Dis. 2008 Oct;62(2):177-81. doi: 10.1016/j.diagmicrobio.2008.07.001. Epub 2008 Aug 8.

Abstract

The in vitro activity of posaconazole and voriconazole was evaluated by MIC, minimum fungicidal concentration (MFC), and time-kill methods. MFCs were determined for 15 Candida krusei and time-killing curves for 5 of these isolates. MFCs were obtained transferring 100 microL from clear MIC wells onto Sabouraud dextrose agar. Time-kill studies were performed in RPMI 1640 medium (5 mL, inoculum approximately 10(5) colony-forming unit [CFU]/mL). Geometric mean (GM) MIC and GM-MFC were 0.2 and 0.72 mg/L for posaconazole and 0.4 and 2.64 mg/L for voriconazole. The killing rate was isolate and concentration dependent; reductions in CFUs start at >or=0.12 mg/L (posaconazole) and >or= 0.5 mg/L (voriconazole). The mean time to reach a 90% growth reduction was 41.5+/-14.2 h (8 mg/L posaconazole) and 48.7+/-61.3 h (32 mg/L voriconazole). By time kill, a 99% killing rate was not reached by either agent. Both methods demonstrated that posaconazole (more active and greater killing rate) and voriconazole have fungicidal activity against C. krusei.

Publication types

  • Comparative Study

MeSH terms

  • Antifungal Agents / pharmacology*
  • Candida / classification
  • Candida / drug effects*
  • Candida / growth & development*
  • Candida / isolation & purification
  • Candidiasis / microbiology
  • Culture Media
  • Drug Resistance, Fungal
  • Fungemia / microbiology
  • Humans
  • Microbial Sensitivity Tests
  • Pyrimidines / pharmacology*
  • Time Factors
  • Triazoles / pharmacology*
  • Voriconazole

Substances

  • Antifungal Agents
  • Culture Media
  • Pyrimidines
  • Triazoles
  • posaconazole
  • Voriconazole